BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 290 filers reported holding BIONTECH SE in Q1 2022. The put-call ratio across all filers is 1.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $93,228,112 | +62.4% | 858,138 | +86.2% | 0.04% | +50.0% |
| Q2 2023 | $57,404,721 | 0.0% | 460,823 | 0.0% | 0.03% | 0.0% |
| Q1 2023 | $57,404,721 | -20.4% | 460,823 | -4.1% | 0.03% | -26.3% |
| Q4 2022 | $72,150,816 | -99.8% | 480,301 | +41.5% | 0.04% | +46.2% |
| Q3 2022 | $45,783,128,000 | +50.0% | 339,436 | +65.8% | 0.03% | +62.5% |
| Q2 2022 | $30,531,654,000 | -0.6% | 204,773 | +13.7% | 0.02% | +23.1% |
| Q1 2022 | $30,713,251,000 | -21.4% | 180,073 | +18.8% | 0.01% | -13.3% |
| Q4 2021 | $39,089,441,000 | +53.6% | 151,627 | +62.6% | 0.02% | +36.4% |
| Q3 2021 | $25,450,039,000 | -10.1% | 93,227 | -26.3% | 0.01% | -8.3% |
| Q2 2021 | $28,320,372,000 | -20.9% | 126,498 | -61.4% | 0.01% | -25.0% |
| Q1 2021 | $35,796,631,000 | +56.1% | 327,838 | +16.6% | 0.02% | +45.5% |
| Q4 2020 | $22,930,108,000 | +136.3% | 281,282 | +100.6% | 0.01% | +120.0% |
| Q3 2020 | $9,705,492,000 | -28.1% | 140,192 | -30.7% | 0.01% | -37.5% |
| Q2 2020 | $13,495,228,000 | – | 202,206 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |